Hello and Welcome to Patientsville.com, Your Source for all ZELMAC information. We are dedicated to provide You with ZELMAC safety information. Learn about ZELMAC serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ZELMAC Safety Reports
Total ZELMAC reports: 220.ZELMAC FDA safety alerts: No.
Reported deaths: 26 Reported hospitalizations: 101.
Take ZELMAC Side Effects Survey or Share Your ZELMAC Story. Read More Here.
Showing 1-75 of 220 Next >
Physician from BRAZIL reported ZELMAC problem on May 09, 2007. Male patient, 71 years of age, weighting 196.2 lb, was diagnosed with diverticulitis, hypertension, cerebrovascular accident prophylaxis and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, vertigo. ZELMAC dosage: 6 MG, ONCE/SINGLE. During the same period patient was treated with SINERGEN, ASPIRIN. Patient recovered.ZELMAC problem was reported by a Pharmacist from TURKEY on May 09, 2007. Female patient was diagnosed with pain and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: asthenia, gait disturbance, hypoaesthesia. ZELMAC dosage: 6 MG, BID. Patient recovered.
Physician from KOREA, REPUBLIC OF reported ZELMAC problem on May 14, 2007. Female patient, 67 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abasia, myocardial ischaemia. ZELMAC dosage: unknown. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CANADA on May 14, 2007. Female patient, 57 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebrovascular accident, colectomy, intestinal haemorrhage. ZELMAC dosage: unknown. During the same period patient was treated with ZELMAC HTF, NEXIUM, LORAZEPAM, VENTOLINLET, MOTILIUM, ENZYMES. Patient was hospitalized. Patient recovered.
Physician from EGYPT reported ZELMAC problem on May 21, 2007. Male patient, 38 years of age, weighting 176.4 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest pain, dyspnoea, ejection fraction decreased, myocarditis, palpitations, tachycardia. ZELMAC dosage: 6 MG/DAY. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from ARGENTINA on May 14, 2007. Female patient, 78 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: angioplasty, anxiety, emotional disorder, myocardial infarction, stent placement. ZELMAC dosage: unknown. During the same period patient was treated with PAROXETINE, RIVOTRIL, LOTRIAL, ATENOLOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MEXICO reported ZELMAC problem on May 18, 2007. Female patient, 57 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: exostosis, limb operation. ZELMAC dosage: 6 MG, BID. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Health Professional from ARGENTINA on May 21, 2007. Female patient, 69 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: emphysema, lung operation, tendonitis. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on May 23, 2007. Female patient, 47 years of age, was diagnosed with colitis and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: haematochezia, nausea. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with NIMESULIDE. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from ARGENTINA on May 22, 2007. Male patient, 72 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, thrombosis. ZELMAC dosage: unknown. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on May 24, 2007. Female patient, 58 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: colonoscopy, haemorrhoid operation, haemorrhoids. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Physician from BRAZIL on May 28, 2007. Male patient, 71 years of age, weighting 196.2 lb, was diagnosed with diverticulitis, hypertension, cerebrovascular accident prophylaxis and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, vertigo. ZELMAC dosage: 6 MG, ONCE/SINGLE. During the same period patient was treated with SINERGEN, ASPIRIN. Patient recovered.
Health Professional from COLOMBIA reported ZELMAC problem on May 28, 2007. Female patient, 81 years of age, was diagnosed with irritable bowel syndrome, hypothyroidism, hypertension and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: chest pain, oesophagitis, peripheral coldness. ZELMAC dosage: 6 MG, QD. During the same period patient was treated with EUTIROX, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on May 28, 2007. Female patient, 52 years of age, weighting 169.8 lb, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure decreased, dizziness, headache, heart rate increased. ZELMAC dosage: unknown. During the same period patient was treated with LEXAPRO. Patient recovered.
Physician from MEXICO reported ZELMAC problem on May 29, 2007. Female patient, 45 years of age, was diagnosed with irritable bowel syndrome, depression and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: syncope. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with ADEPSIQUE. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from COLOMBIA on May 30, 2007. Female patient was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: endometriosis, hysterectomy, vaginal haemorrhage. ZELMAC dosage: 6 MG, BID. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on May 31, 2007. Female patient, 49 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: headache, hysterectomy. ZELMAC dosage: 6MG. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from VENEZUELA on June 06, 2007. Male patient, 54 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hepatic cyst, platelet count decreased, yellow skin. ZELMAC dosage: 6 MG, TID. During the same period patient was treated with ANTIHYPERTENSIVES. Patient was hospitalized. Patient died on 01/17/2007.
Consumer or non-health professional from VENEZUELA reported ZELMAC problem on June 06, 2007. Female patient, 42 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, depression, hepatomegaly, musculoskeletal chest pain, musculoskeletal discomfort, neurectomy, neuroma, upper respiratory tract infection. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with DOLOMAX, CATAFLAM. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Physician from UNITED STATES on June 11, 2007. Female patient, 28 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, cardiomegaly, cardiovascular disorder, chest pain, heart rate increased, tachycardia. ZELMAC dosage: 6 MG, BID. Patient recovered.
Physician from BRAZIL reported ZELMAC problem on June 06, 2007. Female patient, 20 years of age, weighting 99.21 lb, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: anaemia, full blood count abnormal, gastritis, hepatic pain, hepatomegaly, joint swelling, liver disorder, lung infiltration, oedema peripheral. ZELMAC dosage: unknown. During the same period patient was treated with PAROXETINE, NOVIAL. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on June 06, 2007. Female patient, 52 years of age, weighting 169.8 lb, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure decreased, blood pressure increased, dizziness, headache, heart rate increased. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with LEXAPRO. Patient recovered.
Consumer or non-health professional from VENEZUELA reported ZELMAC problem on June 06, 2007. Female patient, 53 years of age, was diagnosed with irritable bowel syndrome, haemorrhoids, constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: paraesthesia. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with DIOVENOR, LACTULOSE. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from COLOMBIA on June 07, 2007. Female patient, 43 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, dyspnoea, tachycardia. ZELMAC dosage: unknown. During the same period patient was treated with HARMETONE. Patient recovered.
Physician from SWITZERLAND reported ZELMAC problem on June 11, 2007. Female patient, 53 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: dizziness, loss of consciousness, syncope, ventricular extrasystoles. ZELMAC dosage: 6-12 MG/DAY. During the same period patient was treated with LESCOL, ATACAND, AMLODIPINE. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from on June 14, 2007. Female patient, 70 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, diarrhoea, dizziness. ZELMAC dosage: 6 MG QD OR BID. During the same period patient was treated with ASPIRIN, BAIXINTONG. Patient recovered.
Consumer or non-health professional from CHINA reported ZELMAC problem on June 15, 2007. Female patient, 51 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: arrhythmia, palpitations. ZELMAC dosage: unknown. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CHINA on June 15, 2007. Female patient, 41 years of age, was diagnosed with abdominal pain and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cardiac discomfort, dyspnoea, myocardial ischaemia. ZELMAC dosage: 6 MG, BID. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on June 14, 2007. Male patient, 65 years of age, was diagnosed with colitis, hypertension and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal distension, gastric lavage, malignant neoplasm of spinal cord. ZELMAC dosage: 6 MG, ONCE/SINGLE. During the same period patient was treated with METHYLDOPA. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from COLOMBIA on June 15, 2007. Male patient, 65 years of age, was diagnosed with irritable bowel syndrome, platelet aggregation, hypertension, diabetes mellitus non-insulin-dependent and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: angina pectoris, chest pain, hyperhidrosis, nausea. ZELMAC dosage: unknown. During the same period patient was treated with PLAVIX, CARVEDILOL, LANITOP, LASIX, EUGLUCON, GLUCOPHAGE, INSULIN. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on June 22, 2007. Female patient, 52 years of age, was diagnosed with irritable bowel syndrome, hypercholesterolaemia and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, cardiac arrest, catheterisation cardiac, resuscitation, sciatica. ZELMAC dosage: unknown. During the same period patient was treated with CHOLESTEROL, ANALGESICS. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CHINA on June 14, 2007. Female patient, 79 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood pressure systolic increased, chest discomfort, coronary artery disease, heart rate increased, influenza, oedema peripheral, palpitations, sinus tachycardia. ZELMAC dosage: 6 MG, BID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on June 21, 2007. Female patient, 47 years of age, was diagnosed with colitis and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: haematochezia, nausea. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with NIMESULIDE. Patient recovered.
ZELMAC problem was reported by a Physician from BRAZIL on June 27, 2006. Female patient was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, gastroenteritis rotavirus, reflux oesophagitis, vomiting. ZELMAC dosage: 6 MG, BID. Patient recovered.
Consumer or non-health professional from CHILE reported ZELMAC problem on July 04, 2006. Female patient, 52 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: infection, large intestine perforation, pain. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with CLINDAMYCIN, METRONIDAZOLE, RANITIDINE. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CHILE on July 06, 2006. Male patient, 57 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: appendicitis. ZELMAC dosage: 6 MG, TID. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on July 04, 2006. Female patient, 74 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abnormal faeces, gastrointestinal disorder, oral surgery, osteomyelitis, pain. ZELMAC dosage: unknown. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CHILE on July 04, 2006. Female patient, 27 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cyst removal, oophorectomy, ovarian abscess, salpingectomy. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with CLINDAMYCIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on July 04, 2006. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, diarrhoea. ZELMAC dosage: 3 MG, BID. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on July 06, 2006. Female patient, 23 years of age, weighting 125.7 lb, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, back disorder, back pain, chest pain, dysentery, dyspnoea, headache. ZELMAC dosage: 6 MG, BID. Patient recovered.
Consumer or non-health professional from CHILE reported ZELMAC problem on July 12, 2006. Female patient, 18 years of age, was diagnosed with abdominal pain upper and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: gallbladder operation. ZELMAC dosage: 6 MG, QD. During the same period patient was treated with SALBUTAMOL. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on July 10, 2006. Female patient, 29 years of age, weighting 127.9 lb, was diagnosed with constipation, flatulence, pain, gastritis, reflux oesophagitis, sleep disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: coeliac disease, diarrhoea, gastric disorder, liver disorder. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with LUFTAL, ESXOR, DICETEL, BUSCOPAN COMP, NEXIUM, MOTILIUM, FRONTAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on July 15, 2006. Female patient, 62 years of age, weighting 136.7 lb, was diagnosed with sleep disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure inadequately controlled, decreased appetite, depression, haemorrhage, malignant neoplasm progression, mental disorder, multi-organ failure, shock. ZELMAC dosage: unknown. During the same period patient was treated with ONDANSETRON, MELILOT, ARGININE, MOTILIUM, TRIMEBUTINE MALEATE, LEXOTAN. Patient was hospitalized. Patient died on 06/30/2006.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on July 04, 2006. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, diarrhoea. ZELMAC dosage: 3 MG, BID. Patient recovered.
Physician from BRAZIL reported ZELMAC problem on July 04, 2006. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, diarrhoea. ZELMAC dosage: 3 MG, BID. Patient recovered.
ZELMAC problem was reported by a Physician from ARGENTINA on July 18, 2006. Female patient, 66 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, surgery, uterine disorder. ZELMAC dosage: 6MG ONCE OR TWICE A DAY. During the same period patient was treated with AGAROL, BIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CHILE reported ZELMAC problem on July 24, 2006. Female patient, 60 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: surgery. ZELMAC dosage: 6 MG, BID. Patient was hospitalized and became disabled. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from ARGENTINA on July 24, 2006. Female patient, 67 years of age, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: ileus. ZELMAC dosage: 1.5 MG, BID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CHILE reported ZELMAC problem on July 04, 2006. Female patient, 52 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: infection, large intestine perforation, pain. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with CLINDAMYCIN, METRONIDAZOLE, RANITIDINE. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Physician from BRAZIL on July 04, 2006. Female patient, 51 years of age, weighting 132.3 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, diarrhoea. ZELMAC dosage: 3 MG, BID. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on July 25, 2006. Female patient, 59 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: colon operation. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from on July 29, 2006. Female patient, 53 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: back pain, bladder spasm, dysuria, kidney infection, polyuria. ZELMAC dosage: 6MG. Patient recovered.
Physician from ARGENTINA reported ZELMAC problem on July 25, 2006. Female patient, 59 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: colon polypectomy, colonic polyp. ZELMAC dosage: 6 MG, BID. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on Aug 05, 2006. Male patient, 72 years of age, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ZELMAC dosage: 6 MG, UNK. Patient died on 05/31/2006.
Consumer or non-health professional from CHILE reported ZELMAC problem on July 31, 2006. Female patient, 69 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: catheter placement, colon cancer, pain, tumour excision. ZELMAC dosage: 6 MG, QD. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from MEXICO on Aug 03, 2006. Female patient, 75 years of age, was diagnosed with diarrhoea and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: diarrhoea. ZELMAC dosage: 6 MG, QID. During the same period patient was treated with DRAMAMINE, ANTIBIOTICS. Patient was hospitalized. Patient recovered.
Physician from VENEZUELA reported ZELMAC problem on Aug 04, 2006. Male patient, 78 years of age, was diagnosed with constipation, prophylaxis and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: arrhythmia, gallbladder operation. ZELMAC dosage: 6 MG, TID. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM, PREGABALIN, RIVOTRIL, TRYPTANOL. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from CHILE on Aug 07, 2006. Female patient was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: rectocele, rectocele repair. ZELMAC dosage: 6 MG, BID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ARGENTINA reported ZELMAC problem on Aug 10, 2006. Female patient, 56 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: rectal fissure. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from on Aug 10, 2006. Female patient, 56 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, depressed mood, gastrointestinal inflammation, haematochezia, headache, intestinal haemorrhage, pyrexia. ZELMAC dosage: unknown. During the same period patient was treated with ESTROGENS CONJUGATED, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MEXICO reported ZELMAC problem on Aug 08, 2006. Female patient, child 6 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal infection. ZELMAC dosage: 6 MG, QD. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on Aug 10, 2006. Female patient, 68 years of age, weighting 127.9 lb, was diagnosed with pain and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back disorder, gait disturbance, insomnia, mobility decreased, nephrolithiasis, osteoarthritis, procedural complication, renal stone removal. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with PASALIX. Patient recovered.
Physician from BRAZIL reported ZELMAC problem on Aug 05, 2006. Male patient, 72 years of age, was diagnosed with gastrointestinal disorder and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ZELMAC dosage: 6 MG, UNK. Patient died on 05/31/2006.
ZELMAC problem was reported by a Physician from BRAZIL on Aug 10, 2006. Female patient, 68 years of age, weighting 127.9 lb, was diagnosed with pain and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back disorder, gait disturbance, insomnia, mobility decreased, nephrolithiasis, osteoarthritis, procedural complication, renal stone removal. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with PASALIX. Patient recovered.
Physician from MEXICO reported ZELMAC problem on Aug 18, 2006. Female patient was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: thrombosis. ZELMAC dosage: 12 MG/DAY. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from ARGENTINA on Aug 10, 2006. Female patient, 56 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: rectal fissure. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported ZELMAC problem on Aug 10, 2006. Female patient, 68 years of age, weighting 127.9 lb, was diagnosed with pain and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back disorder, gait disturbance, insomnia, mobility decreased, nephrolithiasis, osteoarthritis, procedural complication, renal stone removal. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with PASALIX. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from on Aug 10, 2006. Female patient, 56 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, depressed mood, gastrointestinal inflammation, haematochezia, headache, intestinal haemorrhage, pyrexia. ZELMAC dosage: unknown. During the same period patient was treated with ESTROGENS CONJUGATED, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Pharmacist from BRAZIL reported ZELMAC problem on Aug 23, 2006. Female patient, 49 years of age, weighting 136.7 lb, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, hypotension, prostration, vertigo. ZELMAC dosage: 6 MG, BID. Patient recovered.
ZELMAC problem was reported by a Physician from BRAZIL on Aug 23, 2006. Female patient, 28 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: dysphagia, hypoaesthesia, pharyngeal oedema, pruritus, swelling. ZELMAC dosage: 1 TABLET/DAY (6MG 30). Patient recovered.
Consumer or non-health professional from reported ZELMAC problem on Aug 24, 2006. Female patient, 30 years of age, was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: gallbladder operation. ZELMAC dosage: unknown. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from on Aug 24, 2006. Female patient, 31 years of age, weighting 143.3 lb, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fibromyalgia, irritable bowel syndrome, swelling, tendonitis. ZELMAC dosage: 6 MG, UNK. During the same period patient was treated with VOLTAREN. Patient recovered.
Physician from MEXICO reported ZELMAC problem on Aug 18, 2006. Female patient, 36 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, pain in extremity, skin discolouration, surgery, thrombosis. ZELMAC dosage: 12 MG/DAY. Patient was hospitalized. Patient recovered.
ZELMAC problem was reported by a Consumer or non-health professional from BRAZIL on Aug 26, 2006. Female patient, 36 years of age, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: haemorrhage, surgery. ZELMAC dosage: 12 MG/DAY. During the same period patient was treated with LISADOR, LUFTAL. Patient recovered.
Physician from BRAZIL reported ZELMAC problem on June 16, 2006. Female patient, 80 years of age, weighting 198.4 lb, was diagnosed with constipation and was treated with ZELMAC. After drug was administered, patient experienced the following problems/side effects: hypertension, pancreatic carcinoma metastatic. ZELMAC dosage: 6 MG, BID. During the same period patient was treated with TRAMADOL. Patient died on 06/05/2006.
Showing 1-75 of 220 Next >